ask="4.45"
ask_size="500"
average_daily_volume="110422"
bid="4.13"
bid_size="1600"
book_value="2.54"
change="+0.21"
change_from_200_day_moving_average="-1.05"
change_from_50_day_moving_average="-0.11"
change_from_52_week_high="-7.42"
change_From_52_week_low="0.41"
change_in_percent="+5.30%"
close="4.17"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.51"
ebitda="-74.76M"
eps_estimate_current_year="-1.08"
eps_estimate_next_quarter="-0.29"
eps_estimate_next_year="-1.20"
ex_dividend_date="N/A"
float_shares="24541000"
high="4.25"
high_52_weeks="11.59"
last_trade_date="3/2/2017"
last_trade_price="4.17"
last_trade_size="282"
last_trade_time="4:00pm"
low="4.01"
low_52_weeks="3.76"
market_capitalization="295.17M"
moving_average_200_day="5.22"
moving_average_50_day="4.28"
name="Adaptimmune Therapeutics plc"
notes="N/A"
one_year_target_price="14.83"
open="4.01"
pe_ratio="N/A"
peg_ratio="0.28"
percent_change_from_200_day_moving_average="-20.16%"
percent_change_from_50_day_moving_average="-2.55%"
percent_change_from_52_week_high="-64.01%"
percent_change_from_52_week_low="+10.90%"
previous_close="3.96"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.56"
price_per_sales="29.43"
revenue="9.52M"
shares_outstanding="70785000"
short_ratio="3.03"
stock_exchange="NMS"
symbol="ADAP"
volume="361579"
weeks_range_52="3.76 - 11.59"
